\documentclass[journal=jcim,manuscript=suppinfo]{achemso}
\usepackage{amsmath}
\usepackage{graphicx}
\usepackage{hyperref}
\usepackage[table,xcdraw]{xcolor}
\usepackage[left=1.5cm, right=1cm]{geometry}


\makeatletter
\let\oldminipage\minipage
\let\oldendminipage\endminipage
\renewenvironment{minipage}[1]{}{}
\g@addto@macro{\maketitle}{\let\minipage\oldminipage\let\endminipage\oldendminipage}
\makeatother


% fix some achemso rubbish
\renewcommand{\titlesize}{\normalsize}
\renewcommand{\affilsize}{\footnotesize	}
\renewcommand{\authorsize}{\footnotesize	}
\renewcommand{\emailsize}{\footnotesize}

%% Main manuscript contributors
\author{Hugo MacDermott-Opeskin}
\affiliation{Open Molecular Software Foundation, Davis CA, USA}
\author{Jenke Scheen}
\affiliation{Open Molecular Software Foundation, Davis CA, USA}
\author{Cas Wognum}
\affiliation{Valence Labs, Montréal, Québec, Canada}
\altaffiliation{Recursion Pharmaceuticals, Salt Lake City, UT, USA}
\author{Joshua, T Horton}
\affiliation{Open Molecular Software Foundation, Davis CA, USA}
\author{Devany West}
\affiliation{Open Molecular Software Foundation, Davis CA, USA}
\author{Alexander Matthew Payne}
\affiliation{Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA}
\altaffiliation{Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA}
\author{Maria A Castellanos}
\affiliation{Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA}
\author{Sean Colby}
\affiliation{Open Molecular Software Foundation, Davis CA, USA}

%% ASAP %%
\author{Edward Griffen}
\affiliation{MedChemica Consultancy Ltd, Macclesfield, UK}
\author{David Cousins}
\affiliation{MedChemica Consultancy Ltd, Macclesfield, UK}
\author{Jessica Stacey}
\affiliation{MedChemica Consultancy Ltd, Macclesfield, UK}
\author{Jasmin Cara Aschenbrenner}
\affiliation{Diamond Light Source, Didcot, UK}
\author{Daren Fearon}
\affiliation{Diamond Light Source, Didcot, UK}
\author{Blake Balcomb}
\affiliation{Diamond Light Source, Didcot, UK}
\author{Peter Marples}
\affiliation{Diamond Light Source, Didcot, UK}
\author{Charles W.E. Tomlinson}
\affiliation{Diamond Light Source, Didcot, UK}
\author{Ryan Lithgo}
\affiliation{Diamond Light Source, Didcot, UK}
\author{Max Winokan}
\affiliation{Diamond Light Source, Didcot, UK}
\author{Haim Barr}
\affiliation{Weizmann Institute of Science, Rehovot, IL}
\author{Noa Lahav}
\affiliation{Weizmann Institute of Science, Rehovot, IL}
\author{Gwendolyn Fate}
\affiliation{Thames Pharma Partners, USA}
\author{Bruce Lefker}
\affiliation{Thames Pharma Partners, USA}
\author{Ralph Robinson}
\affiliation{Thames Pharma Partners, USA}
\author{Tamas Szommer}
\affiliation{Centre for Medicines Discovery, Oxford, UK}
\author{Nick Lynch}
\affiliation{Curlew Research, UK}


%% OpenADMET
\author{Ryan Renslow}
\affiliation{Open Molecular Software Foundation, Davis CA, USA}
\author{Mallory Tollefson}
\affiliation{Open Molecular Software Foundation, Davis CA, USA}
\author{Cynthia Xu}
\affiliation{Open Molecular Software Foundation, Davis CA, USA}

% Valence 
\author{Jonny Hsu}
\affiliation{Valence Labs, Montréal, Québec, Canada}
\altaffiliation{Recursion Pharmaceuticals, Salt Lake City, UT, USA}
\author{Julien St-Laurent}
\affiliation{Valence Labs, Montréal, Québec, Canada}
\altaffiliation{Recursion Pharmaceuticals, Salt Lake City, UT, USA}
\author{Honore Etsmoberg}
\affiliation{Valence Labs, Montréal, Québec, Canada}
\altaffiliation{Recursion Pharmaceuticals, Salt Lake City, UT, USA}
\author{Lu Zhu}
\affiliation{Valence Labs, Montréal, Québec, Canada}
\altaffiliation{Recursion Pharmaceuticals, Salt Lake City, UT, USA}
\author{Andrew Quirke}
\affiliation{Valence Labs, Montréal, Québec, Canada}
\altaffiliation{Recursion Pharmaceuticals, Salt Lake City, UT, USA}

%% Participants
% All participants excluding the authors already listed in the main document
\author{Mohamed Iliyas Abdul Haleem}

\author{Irfan Alibay}
\affiliation{Open Molecular Software Foundation, Davis CA, USA}

\author{Gunjan Baid}
\affiliation{Inductive Bio, New York, NY, USA}

\author{Benjamin Birnbaum}
\affiliation{Inductive Bio, New York, NY, USA}

\author{Kevin Bishop}
\affiliation{Ontario Institute for Cancer Research, Toronto, ON, Canada}

\author{Hugo Bohorquez}
\affiliation{Ontario Institute for Cancer Research, Toronto, ON, Canada}

\author{Ashmita Bose}
\affiliation{University of Luxembourg, Luxembourg City, Luxembourg}

\author{C.J. Brown}
\affiliation{Alpha29, LLC}

\author{Jackson Burns}
\affiliation{MIT, Cambridge, MA, USA}

\author{Lianjin Cai}
\affiliation{University of Pittsburgh, Pittsburgh, PA, USA}

\author{Ruel Cedeno}
\affiliation{Novalix, 67000 Strasbourg, France}

\author{Vladimir Chupakhin}
\affiliation{Simulations Plus, Research Triangle Park, NC, USA}

\author{Finlay Clark}
\affiliation{Newcastle University, Newcastle, UK}

\author{Daniel Cole}
\affiliation{Newcastle University, Newcastle, UK}

\author{Carles Corbi-Verge}
\affiliation{Recursion, Salt Lake City, UT, USA}

\author{Muhammad Danial}
\affiliation{Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China}

\author{Alec Davi}
\affiliation{Owkin, New York, NY, USA}

\author{Wim Dehaen}
\affiliation{UCT Prague, Prague, Czech Republic}

\author{Niklas Piet Doering}
\affiliation{Freie Universität Berlin, Berlin, Germany}

\author{Alexis Dougha}
\affiliation{BFA, Université Paris Cité, CNRS UMR 8251, Inserm U1133, 75013 Paris, France}

\author{Bryce Eakin}
\affiliation{Inductive Bio, New York, NY, USA}

\author{Anatol Ehrlich}
\affiliation{University of Vienna, Vienna, Austria}

\author{Rokas Elijosius} % [Pending check]
\affiliation{University of Cambridge, Cambridge, UK}

\author{Jozef Fülöp}
\affiliation{UCT Prague, Prague, Czech Republic}

\author{Anthony Gitter}
\affiliation{University of Wisconsin-Madison, Madison, WI, USA}
\altaffiliation{Morgridge Institute for Research, Madison, WI, USA}

\author{Yaowen Gu}
\affiliation{New York University, New York, NY, USA}

\author{Teresa Head-Gordon}
\affiliation{University of California, Berkeley, CA, USA}

\author{Ellena Jiang}
\affiliation{University of Vienna, Vienna, Austria}

\author{Benjamin Kaminow}
\affiliation{Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA}

\author{Sina Khosravi}
\affiliation{Mashhad University of Medical Sciences, Mashhad, Khorasan Razavi, Iran}

\author{Asma Feriel Khoualdi} % [Pending check]
\affiliation{Newcastle University, Newcastle, UK}

\author{Eelke Bart Lenselink}
\affiliation{Galapagos NV, 2800 Mechelen, Belgium}

\author{Zhirong Liu}
\affiliation{Peking University, Beijing, China}

\author{Yue Liu}
\affiliation{University of Pittsburgh, Pittsburgh, PA, USA}

\author{Sijie Liu}
\affiliation{Freie Universität Berlin, Berlin, Germany}

\author{Yizhou Ma}
\affiliation{QuantaBricks, Newark, NJ, USA}

\author{Patrick Maher}
\affiliation{Inductive Bio, New York, NY, USA}

\author{Imke Mayer} % [Pending Check]
\affiliation{Owkin, New York, NY, USA}

\author{Antonia Mey}
\affiliation{University of Edinburgh, Edinburgh, Scotland, UK}

\author{Floriane Montanari} % [Pending check]
\affiliation{Owkin, New York, NY, USA}

\author{Taoyu Niu}
\affiliation{University of Pittsburgh, Pittsburgh, PA, USA}

\author{Ryusei Ogino}
\affiliation{Japan Tobacco INC., Minato City, Tokyo, Japan}

\author{Ashok Palaniappan}
\affiliation{SASTRA Deemed University, Thanjavur, Tamil Nadu 613401, India}

\author{Xiaolin Pan}
\affiliation{New York University, New York, NY, USA}

\author{Auro Patnaik}
\affiliation{University of Edinburgh, Edinburgh, Scotland, UK}

\author{Long-Hung Pham}
\affiliation{Imperial College London, London, UK}

\author{Luis Pinto}
\affiliation{Independent Researcher}

\author{Justin Purnomo}
\affiliation{University of California, Berkeley, CA, USA}

\author{Alexander Rich}
\affiliation{Inductive Bio, New York, NY, USA}

\author{Lars Schaaf}
\affiliation{University of Cambridge, Cambridge, UK}

\author{Christoph Schran}
\affiliation{University of Cambridge, Cambridge, UK}

\author{Satya Pratik Srivastava}
\affiliation{Shiv Nadar University, Greater Noida, Uttar Pradesh, India}

\author{Kunyang Sun}
\affiliation{University of California, Berkeley, CA, USA}

\author{Zhaoxi Sun}
\affiliation{Shenzhen University of Advanced Technology, Shenzhen, China}

\author{Valerij Talagayev}
\affiliation{Freie Universität Berlin, Berlin, Germany}

\author{Balamurugan Thirukonda Subramanian Balakrishnan}

\author{Alexandre Tkatchenko}
\affiliation{University of Luxembourg, Luxembourg City, Luxembourg}

\author{Wojtek Treyde}
\affiliation{University of Oxford, Oxford, UK}

\author{Austin Tripp}
\affiliation{Valence Labs, Quebec, Canada}

\author{Nopsinth Vithayapalert}
\affiliation{VISTEC, Pa Yup Nai, Thailand}

\author{Yingze Wang}
\affiliation{University of California, Berkeley, CA, USA}

\author{Azmine Toushik Wasi}
\affiliation{Shahjalal University of Science and Technology, Sylhet, Bangladesh}

\author{Steffen Wedig}
\affiliation{University of Cambridge, Cambridge, UK}

\author{Bofei Xu}
\affiliation{Peking University, Beijing, China}

\author{Weijun Zhou}
\affiliation{New York University, New York, NY, USA}



%% ASAP PIs
\author{Frank von Delft}
\affiliation{Diamond Light Source, Didcot, UK}
\author{Alpha Lee}
\affiliation{PostEra, Cambridge, MA, USA}
\author{Karla Kirkegaard}
\affiliation{Stanford University School of Medicine: Stanford, CA, US}
\author{Peter Sjö}
\affiliation{Drugs for Neglected Diseases initiative: Geneva, Genève, CH}

%% OpenADMET PIs
\author{Sri Kosuri} 
\affiliation{Octant Inc: Emeryville, CA, US}

\author{James S. Fraser}
\affiliation{University of California San Francisco, San Francisco, CA, USA}

%% John as final as PI across both
\author{John D. Chodera}
\affiliation{Memorial Sloan Kettering Cancer Center, New York, NY, USA}

\email{*jenke.scheen@omsf.io}


% Title 
\title{A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data}

\begin{document}

\maketitle

\begin{figure}
    \includegraphics[scale=0.175]{SI/fig_S1_ADMET_dynamic_ranges/admet_endpoints.png}
    \includegraphics[scale=0.175]{SI/fig_S1_ADMET_dynamic_ranges/admet_endpoints_log10.png}
  \caption{Distributions of ADMET endpoints for train (blue) and test (orange) show outlier and dynamic range difficulties.  HLM, MLM, and Permeability have long tails, KSOL, has mostly low and high values within this dynamic range.  Raw values (top) and log10 values (bottom).}
  \label{fgr:admet_endpoints}
\end{figure}



\begin{figure}
    \includegraphics[scale=0.75]{SI/fig_S2_ktau_potency_leaderboard/SI_potency_leaderboards.png}
  \caption{Participants performed diversely on potency predictions. A) leaderboard of the potency subchallenge as each entry's category (DL=Deep Learning, ML=Machine Learning, PB=Physics-Based, GP=Gaussian Process, LR=Linear Regression) and split by target; MERS-CoV Mpro in yellow, SARS-CoV-2 Mpro in green). B) replication of panel A but using the ranking metric \textit{kendall's $\tau$ }. Baseline models as deployed by the organizers are marked with asterisks. Each entry is annotated with its statistical ranking by the Compact Letter Display (CLD) system.}
  \label{fgr:ktau_supp_potency}
\end{figure}



\begin{figure}
    \includegraphics[scale=0.75]{SI/fig_S3_poses_by_series/success_rate_lead_vs_backup_comparison.png}
  \caption{Success rates of each type of model on the lead series vs backup series. This shows that the worse performance on the backup series comes mainly from the physics-based models, with the co-folding models doing well on both and the deep-learning doing poorly on both.}
  \label{fgr:success_rate_lead_vs_backup}
\end{figure}

\begin{figure}
    \includegraphics[scale=0.75]{SI/fig_S4_data_preparation/Figure.png}
  \caption{Data preparation workflow for the blind challenge. From $\sim$8k experimental measurements (top), 356 compound measurements were omitted completely from the challenge due to their proximity to the to-be-announced preclinical candidate. Another $\sim$1.8k measurements were removed due to their semi-quantitative nature (i.e. falling outside of assays' dynamic ranges). Remaining data was split temporally by synthesis actioning date at a 75/25 split. Finally, post-hoc adjustments were made to ensure that racemic/enantiomeric measurements were binned into same (training or test) set and that as many compounds as possible were assigned to the (training or test) set across subchallenges or ADMET endpoints.}
  \label{fgr:success_rate_lead_vs_backup}
\end{figure}

\end{document}
